05/29/2025
10:21 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
7:35 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
5:49 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
3:12 PM | MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/20/2025
3:14 PM | MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
5:05 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form DEF 14A | |
05/16/2025
5:07 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form ARS | |
05/15/2025
8:02 PM | Redmile Group, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/08/2025
9:18 AM | Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
05/08/2025
7:10 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:35 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for SLN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/08/2025
6:08 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2025
7:03 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
7:06 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form PRE 14A | |
05/02/2025
9:28 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
6:13 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
5:50 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2025
8:28 AM | Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
04/24/2025
6:16 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2025
9:35 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2025
1:17 PM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
6:50 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
9:47 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
9:50 AM | Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
03/06/2025
10:03 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
4:20 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
3:30 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
3:13 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
9:59 AM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
7:03 PM | Redmile Group, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/11/2025
5:41 PM | Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/02/2025
3:32 PM | HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:34 PM | Davidson Michael H. (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:36 PM | Ede-Golightly James (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:38 PM | Ross Iain (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:39 PM | Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
TOOMAN CRAIG A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:43 PM | Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
7:00 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
4:32 PM | Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/09/2024
7:12 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2024
3:54 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Elon’s “Secret Mission” (Ad) Tesla, SpaceX and Starlink made billions for investors...
But a meeting Elon had on March 21st, 2025, could have a bigger impact than all that combined...
…and send shares of one small-company up 5,889%. Get the name of the stock here >>> |
11/14/2024
8:44 AM | Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:24 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2024
4:20 PM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form F-3ASR | |
08/15/2024
8:05 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/02/2024
5:51 PM | Invus Global Management, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
| Form SC 13G/A | |
06/27/2024
6:40 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2024
7:38 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
7:41 AM | Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buy SLN Stock Free SLN Stock Alerts